Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on March 2, 2021. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Pharmacy Rx Refill

Closed
HT001121R0011Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

NAICS

511120 - Periodical Publishers

Place of Performance

Falls Church, VA, 22042, USA

Set-Aside

WOSB

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
Contacts2 people available
OfficeFALLS CHURCH, VA, 22042, USA
Office AddressFALLS CHURCH, VA, 22042, USA
Contacts

Full Description

Show more
Intend to Award Sole Source to: MUMPS AUDIOFAX, INC. THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency, Falls Church, VA intends to award a firm fixed price sole source contract under the authority of FAR 8.405-6(a)(1)(i)(B), only one source to: MUMPS AUDIOFAX, INC., 744 W. LANCASTER AVE., STE 250, Wayne, PA 19087. The objective of this sole source award is to acquire continued automated prescription refill requests, appointment / referral reminder notification for 9.6 million DoD beneficiaries and interoperability with the legacy and deploying Electronic Health Records (EHR), Composite Health Care System (CHCS) and MHS GENESIS respectively. Interactive Voice Response (IVR) services for the Military Treatment Facilities (MTFs) are needed to support requirements for a standardized beneficiary centric automated telephony solution. Interoperability requirements as part of the transition from the legacy EHR necessitates a tri-phased approach, which entails supporting, (1) prescription refill requests and appointment / referral reminder notifications for the legacy system; (2) a dual connectivity capability, sustaining the legacy operations for one year, while simultaneously supporting prescription refill requests within MHS GENESIS; and (3) a full transition to MHS GENESIS interoperability sustainment. The Sole source is based on only one responsible source as MUMPS AUDIOFAX, INC. is the only contractor that has the knowledge of the Defense Health Agency Pharmacy Rx Refill system . The NAICS Code for this requirement is 511120; the small business size standard is $41.5 million. This notice of intent is not a request for competitive quotes; however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. All information received by 12:0000PM EST on March 5, 2021 may be considered by the Government. Responses shall be submitted to Michael Hunter, Contract Analyst, michael.a.hunter36.ctr@mail.mil and Leslie Nelson, Contracting Officer, leslie.s.nelson7.civ@mail.mil. The email subject line shall state, Intent to Sole Source to MUMPS AUDIOFAX, INC. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 811210
New
Federal
Zeiss Meditec Ophthalmology Equipment Maintenance
Solicitation # HT940627QE003
Solicitation HT940627QE003 is a Request for Quote issued by the Defense Health Agency, Healthcare Contracting Division-Southeast, for a firm-fixed-price contract to provide full-service maintenance for Zeiss MediTec ophthalmology equipment at the Naval Medical Center Camp Lejeune in North Carolina. The scope of work includes regularly scheduled preventative maintenance, timely onsite repairs, and software updates for specific devices, including the CIRRUS 5000, IOLMASTER 700, HFA3 B60, and ATLAS 900. All services must be performed according to manufacturer recommendations and applicable FDA regulations. The contract consists of a base period from December 1, 2026, to November 30, 2027, with four subsequent option periods extending the potential performance through November 30, 2031. This procurement is a total small business set-aside under NAICS code 811210. Award will be made based on the Lowest Priced Technically Acceptable (LPTA) basis, where technical capability is evaluated independently of price. Offerors must submit two separate volumes: Volume I for technical capability, which must describe the functional approach and methodology without identifying company names or logos, and Volume II for comprehensive pricing. Quotes are due by 8:00 am Eastern Time on October 29, 2026. Payment and invoicing will be processed electronically through the Wide Area WorkFlow system.
Electronic and Precision Equipment Repair and Maintenance

POSTED

2 days ago

DEADLINE

in 8 days
View Details
NAICS: 541715
New
Federal
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Solicitation # HT9427-26-R-E020
The Defense Health Agency Contracting Activity is seeking a single award for the development of a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This product must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent the spread of organisms and systemic infections in combat scenarios. The project aims to advance technologies from a preferred Technology Readiness Level of 5 or higher to a final state of TRL 7 or 8, culminating in mandatory U.S. Food and Drug Administration approval or clearance. The scope of work includes preclinical testing, human clinical trials, and the submission of regulatory packages such as New Drug Applications or Premarket Approval Applications. This procurement is conducted under prototype Other Transaction Authority 10 U.S.C. 4022, meaning standard FAR and DFARS regulations do not apply unless expressly referenced. The estimated period of performance is 48 months, divided into three primary objectives: prototype demonstration, clinical studies and regulatory submissions, and final FDA clearance. Proposals are due by November 6, 2026, and must be submitted in three distinct volumes covering technical approach, management capability, and administrative cost and price. To be eligible, offerors must be registered in the System for Award Management and meet specific criteria, such as being a nontraditional defense contractor or a small business.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

2 days ago

DEADLINE

in 16 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS